Outcomes of patients undergoing allogeneic haematopoietic stem cell transplantation for congenital amegakaryocytic thrombocytopenia; a study on behalf of the PDWP of the EBMT

Clémence Aldebert(Assistance Publique – Hôpitaux de Paris), Selim Corbacioglu(Unknown), Mikael Sundin(Karolinska University Hospital), Rose‐Marie Hamladji(Centre de Recherche Nucléaire d’Alger), Jean‐Hugues Dalle(Inserm), Jerry Stein(Schneider Children's Medical Center), Franco Locatelli(Bambino Gesù Children's Hospital), Peter Bader(Goethe University Frankfurt), Arnaud Dalissier(Inserm), Susana Riesco(Instituto de Investigación Biomédica de Salamanca), Nuno Miranda(IPO Porto), Pietro Merli(Children's Hospital of Philadelphia), Marco Zecca(Policlinico San Matteo Fondazione), Birgit Burkhardt(University Hospital Münster), Maura Faraci(Istituto Giannina Gaslini), Marie Angoso(Centre Hospitalier Universitaire de Bordeaux), Alphan Küpesiz(Akdeniz University), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Jacques‐Emmanuel Galimard(Hôpital Saint-Antoine), Robert Wynn(Royal Manchester Children's Hospital), Marianne Ifversen(Copenhagen University Hospital), Victoria Bordon(Ghent University Hospital), Natalia Maximova(IRCCS Materno Infantile Burlo Garofolo), Concha Herrera(Hospital Universitario Reina Sofía), Tayfun Güngör, Mony Fahd(Délégation Paris 7), Ibrahim Ghemlas(King Faisal Specialist Hospital & Research Centre), Alexander B. Mohseny(Leiden University Medical Center), Juliana Silva(Great Ormond Street Hospital), Krzysztof Kałwak(Poznan University of Medical Sciences)
Bone Marrow Transplantation
September 18, 2024
Cited by 3


Related Papers